USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Note K - Equity-based Compensation (Tables)

v3.22.0.1

Note K - Equity-based Compensation (Tables)

12 Months Ended

Jan. 01, 2022

Notes Tables

Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]

2022	$	13,861
2023		7,594
2024		4,203
2025		407
	$	26,065

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	*Year Ended*

	*2021*			*2020*			*2019*

Expected volatility (1)		43.28	%		35.23	%		37.21	%
Risk-free interest rate (2)		0.33	%		1.66	%		2.53	%
Expected life (3)	3.5 yrs.				3.5 yrs.			3.5 yrs.
Expected dividend yield (4)		0.00	%		0.00	%		0.00	%
Weighted-average exercise price (5)	$	85.19		$	63.02		$	116.06

Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]

	Shares			Weighted-average exercise price		Weighted-average remaining contractual term		Aggregate intrinsic value*
Outstanding at January 2, 2021		444		$	69.25		2.0	$	5,434
Granted		12			85.19
Exercised		(304	)		63.40
Forfeited		(2	)		73.81
Expired		-			-

Outstanding at January 1, 2022		150		$	82.22		2.3	$	3,596

Exercisable at January 1, 2022		33		$	103.40		1.8	$	299

Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

	Shares			Weighted-average grant date fair value
Outstanding at January 2,2021		323		$	76.51
Granted		177			86.92
Vested		(131	)		78.29
Forfeited		(3	)		81.41

Outstanding at January 1,2022		366		$	80.87

Schedule of Nonvested Share Activity [Table Text Block]

	Shares			Weighted-average grant date fair value
Nonvested at January 2,2021		11		$	75.85
Granted		6			85.19
Vested		(3	)		80.15
Forfeited		(2	)		80.75

Nonvested at January 1,2022		12		$	78.66

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration